1. United States Food and Drug Administration, Center for Drug Evaluation and Research. Statistical approaches to establishing bioequivalence. Guidance for industry: statistical approaches to establishing bioequivalence. 2001. https://www.fda.gov/media/70958/download
2. European Medicines Agency, Committee for Human Medicinal Products. Investigation of bioequivalence. CHMP CPMP/EWP/QWP/1401/98 Rev. 1. 2010. http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500070039.
3. World Health Organization. Annex 7, Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability. WHO Technical Report Series No. 992, 2015. https://www.who.int/medicines/areas/quality_safety/quality_assurance/Annex7-TRS992.pdf.
4. Health Canada. Conduct and analysis of comparative bioavailability studies. February 2012, June 2018. https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/bioavailability-bioequivalence/conduct-analysis-comparative.pdf
5. United States Food and Drug Administration, Center for Drug Evaluation and Research. Approval package for ANDA 77-883, December 2007.